2022
Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021
Gupta R, Morten CJ, Zhu AY, Ramachandran R, Shah ND, Ross JS. Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021. JAMA Health Forum 2022, 3: e221096. PMID: 35977259, PMCID: PMC9123500, DOI: 10.1001/jamahealthforum.2022.1096.Peer-Reviewed Original ResearchConceptsCross-sectional studyNovel drugsTherapeutic valueUS FoodDrug AdministrationWorld Health Organization Model ListGeneric approvalCapsule formMultivariable analysisAccelerated approvalClinical usefulnessMAIN OUTCOMEPrescription drugsBrand-name drugsModel ListEssential medicinesDrugsApproval statusMedicine inclusionFDANovel tabletBlockbuster statusApprovalAdministrationDrug sales
2018
Cost-Related Insulin Underuse Is Common and Associated with Poor Glycemic Control
HERKERT D, VIJAYAKUMAR P, LUO J, SCHWARTZ J, RABIN T, DEFILIPPO E, LIPSKA K. Cost-Related Insulin Underuse Is Common and Associated with Poor Glycemic Control. Diabetes 2018, 67 DOI: 10.2337/db18-2-or.Peer-Reviewed Original ResearchCost-related underusePoor glycemic controlGlycemic controlDiabetes CenterCross-sectional surveyDM durationPrimary outcomeLess insulinHigher oddsPatientsSmall dosesDrug coverageLogistic regressionInsulinUnderuseMedicaid ServicesEssential medicinesNational InstituteInsulin 3Lower income levelsInsulin 5AgePositive responseHealthUrgent needAffordability and availability of off-patent drugs in the United States—the case for importing from abroad: observational study
Gupta R, Bollyky TJ, Cohen M, Ross JS, Kesselheim AS. Affordability and availability of off-patent drugs in the United States—the case for importing from abroad: observational study. The BMJ 2018, 360: k831. PMID: 29555641, PMCID: PMC5858606, DOI: 10.1136/bmj.k831.Peer-Reviewed Original ResearchConceptsOff-patent drugsObservational studyRare diseasePrescription drugsPatent drugsStudy drugTotal Medicaid spendingCardiovascular diseaseOrphan drug designationPsychiatric diseasesDrug AdministrationPatient accessInfectious diseasesDiseaseDrug characteristicsEssential medicinesDrugsGeneric versionsGeneric drugsMedicaid spendingNovel tabletRegulatory agenciesFDAUnited StatesTreatment areaDisparities in availability of essential medicines to treat non-communicable diseases in Uganda: A Poisson analysis using the Service Availability and Readiness Assessment
Armstrong-Hough M, Kishore SP, Byakika S, Mutungi G, Nunez-Smith M, Schwartz JI. Disparities in availability of essential medicines to treat non-communicable diseases in Uganda: A Poisson analysis using the Service Availability and Readiness Assessment. PLOS ONE 2018, 13: e0192332. PMID: 29420640, PMCID: PMC5805288, DOI: 10.1371/journal.pone.0192332.Peer-Reviewed Original ResearchConceptsNon-communicable diseasesHIV servicesHealth centersHealth facility preparednessHealth service readinessEssential medicinesPrimary health centersReferral health centersHealth facility typeUgandan health facilitiesFacility typePoisson regression modelsHIV careHIV counselingFacility preparednessReadiness assessment toolGeneral HospitalPredictors of readinessHealth facilitiesService readinessMultivariate analysisSignificant associationDiagnostic capacityHigher countsMultivariate model
2017
Disparities in Availability of Essential Medicines to Treat Non-communicable Diseases in Uganda: A Cross-sectional Poisson Analysis Using the 2013 Service Availability and Readiness Assessment
Armstrong-Hough M, Schwartz J, Kishore S. Disparities in Availability of Essential Medicines to Treat Non-communicable Diseases in Uganda: A Cross-sectional Poisson Analysis Using the 2013 Service Availability and Readiness Assessment. Annals Of Global Health 2017, 83: 138-139. DOI: 10.1016/j.aogh.2017.03.309.Peer-Reviewed Original Research
2016
The growing threat of non-communicable disease to pregnancy health
Hawley N. The growing threat of non-communicable disease to pregnancy health. Pacific Journal Of Reproductive Health 2016, 1 DOI: 10.18313/pjrh.2016.909.Peer-Reviewed Original ResearchNon-communicable diseasesChild health effortsPrevalence of obesityRelated non-communicable diseasesSkilled health providersChronic hypertensionObstetric populationMaternal deathsNewborn deathsPregnancy healthPregnant womenGlobal maternalHealth effortsHealth providersAdequate nutritionEssential medicinesDiseaseDeathHypertensionPrematurityObesityDiabetesMaternalMortalityPrevalence
2009
A Role for Community Health Promoters in Tuberculosis Control in the State of Chiapas, Mexico
Herce ME, Chapman JA, Castro A, García-Salyano G, Khoshnood K. A Role for Community Health Promoters in Tuberculosis Control in the State of Chiapas, Mexico. Journal Of Community Health 2009, 35: 182-189. PMID: 20033836, DOI: 10.1007/s10900-009-9206-0.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultCommunity Health PlanningCommunity Health ServicesCommunity Health WorkersComplementary TherapiesFemaleHealth Knowledge, Attitudes, PracticeHealth PromotionHumansInterviews as TopicMaleMedicine, TraditionalMexicoMiddle AgedMultilingualismQualitative ResearchRural Health ServicesTuberculosisVolunteersWorkforceYoung AdultConceptsHealth promotersCommunity health promotersTuberculosis Control ProgrammeCommunity health workersHealth care infrastructureMedicinal plant therapyTB controlTuberculosis controlTB epidemicPublic health workHealth workersParasitic infectionsIndian ethnicityPatientsCare infrastructurePlant therapiesAllopathic medicineEssential medicinesHealth workMedicine cabinetOne-thirdStructured interviewsControl programsOne-fifthBiomedical treatment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply